Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease.
The chronic inflammatory liver disease primary sclerosing cholangitis (PSC) is associated with portal inflammation and the development of neolymphoid tissue in the liver. More than 70% of patients with PSC have a history of inflammatory bowel disease and we have previously reported that mucosal addr...
Auteurs principaux: | Grant, A, Goddard, S, Ahmed-Choudhury, J, Reynolds, G, Jackson, D, Briskin, M, Wu, L, Hübscher, S, Adams, D |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2002
|
Documents similaires
-
Characterization of CCL21 expression in human secondary lymphoid organs and ectopic lymphoid tissues
par: Bugatti, S, et autres
Publié: (2007) -
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis.
par: Manzo, A, et autres
Publié: (2007) -
Overexpression of CCL-21/Secondary Lymphoid Tissue Chemokine in Human Dendritic Cells Augments Chemotactic Activities for Lymphocytes and Antigen Presenting Cells
par: Strieter Robert, et autres
Publié: (2003-11-01) -
CCL21 relationship with lymphoid neogenesis and lymphatic vascular system in chronically inflamed synovium
par: Manzo, A, et autres
Publié: (2005) -
Chemokines and Innate Lymphoid Cells in Skin Inflammation
par: Zhengwang Sun, et autres
Publié: (2021-11-01)